Friday - November 13, 2026

Primary Sclerosing Cholangitis Drugs in Development 2026: Pipeline Therapies, Ongoing Trials, and Companies Driving Innovation | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma

(Albany, New York) – November 13, 2026: As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of … Continue reading →

Osteoporosis Market on the Rise: Growth Opportunities, Challenges, and Future Outlook Through 2036 | Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine

The Key Osteoporosis Companies in the market include – Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, and others.   (Albany, New York) – November 13, 2026: DelveInsight’s “Osteoporosis Market … Continue reading →